---
title: "Abbott Laboratories — Ownership Dossier"
canonical: https://whiteintel.dev/entity/65dc6b99-3bf1-464d-af81-52b19d00a5d5
json: https://whiteintel.dev/api/public/dossier/65dc6b99-3bf1-464d-af81-52b19d00a5d5
identifier: gb-coh:0814-222-0
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Abbott Laboratories

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `gb-coh:0814-222-0`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/65dc6b99-3bf1-464d-af81-52b19d00a5d5  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/65dc6b99-3bf1-464d-af81-52b19d00a5d5  

## Ownership & control

### Holdings / subsidiaries

- **ALLERGY THERAPEUTICS PLC** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/88e63737-eab5-59cd-8867-7395d040ea2e
- **ALERE AS HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bf7387ff-fbd5-5443-b308-f84f4c3818c7
- **ALERE TECHNOLOGIES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/ef4f892e-5733-5778-be3f-afcdaa1ae11f
- **Abbott Laboratories** (beneficial owner) — https://whiteintel.dev/entity/33d7dee0-ac9f-5e7f-940f-ba0e149c22cc
- **ABBOTT MEDICAL U.K. LIMITED** (beneficial owner) — https://whiteintel.dev/entity/e6200905-6c45-5df3-9052-f2ed44fb03e6

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Abbott Laboratories**. Human view: https://whiteintel.dev/entity/65dc6b99-3bf1-464d-af81-52b19d00a5d5 · Structured JSON: https://whiteintel.dev/api/public/dossier/65dc6b99-3bf1-464d-af81-52b19d00a5d5._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._